Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May 4:6:25251.
doi: 10.1038/srep25251.

High rate of drug resistance among tuberculous meningitis cases in Shaanxi province, China

Affiliations

High rate of drug resistance among tuberculous meningitis cases in Shaanxi province, China

Ting Wang et al. Sci Rep. .

Abstract

The clinical and mycobacterial features of tuberculous meningitis (TBM) cases in China are not well described; especially in western provinces with poor tuberculosis control. We prospectively enrolled patients in whom TBM was considered in Shaanxi Province, northwestern China, over a 2-year period (September 2010 to December 2012). Cerebrospinal fluid specimens were cultured for Mycobacterium tuberculosis; with phenotypic and genotypic drug susceptibility testing (DST), as well as genotyping of all positive cultures. Among 350 patients included in the study, 27 (7.7%) had culture-confirmed TBM; 84 (24.0%) had probable and 239 (68.3%) had possible TBM. DST was performed on 25/27 (92.3%) culture positive specimens; 12/25 (48.0%) had "any resistance" detected and 3 (12.0%) were multi-drug resistant (MDR). Demographic and clinical features of drug resistant and drug susceptible TBM cases were similar. Beijing was the most common genotype (20/25; 80.0%) with 9/20 (45%) of the Beijing strains exhibiting drug resistance; including all 3 MDR strains. All (4/4) isoniazid resistant strains had mutations in the katG gene; 75% (3/4) of strains with phenotypic rifampicin resistance had mutations in the rpoB gene detected by Xpert MTB/RIF®. High rates of drug resistance were found among culture-confirmed TBM cases; most were Beijing strains.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Flow diagram of patients in whom tuberculous meningitis was considered and special investigations done.
TBM-tuberculous meningitis; M. tuberculosis-Mycobacterium tuberculosis; ZN-Ziehl-Neelsen; CSF-Cerebral Spinal Fluid; DST-Drug Susceptibility Testing; MIC-Minimal Inhibitory Concentration; Spoligo- spacer oligonucleotide; MIRU-25-25 locus Multiple Interspersed Repetitive Unit; *Classification according to consensus uniform research case definition criteria.
Figure 2
Figure 2. MIRU-25 phylogenetic relationship of M. tuberculosis genotypes identified in TBM patients; with associated spoligotype.
MIRU-25–25 locus Multiple Interspersed Repetitive Unit typing as defined in Methods; Strain No.- Liquid MGIT960 culture positive TBM isolates were assigned numbers 1–27 (2 isolates were not recovered successfully on Lowenstein-Jensen solid medium); SIT - Spoligo International Type; SpoIDB4.0-Fourth International Spoligotyping Database; SpolDB4 ID - Identification from the SpoIDB4.0 database; NA-Unclassified in SpoIDB4.0 database, we defined it as an atypical Beijing strain; *Reference strain.

References

    1. Brancusi F., Farrar J. & Heemskerk D. Tuberculous meningitis in adults: a review of a decade of developments focusing on prognostic factors for outcome. Future Microbiol. 7, 1101–1116 (2012). - PubMed
    1. Thwaites G. E., van Toorn R. & Schoeman J. Tuberculous meningitis: more questions, still too few answers. Lancet Neurol. 12, 999–1010 (2013). - PubMed
    1. Koh W. J., Ko Y., Kim C. K., Park K. S. & Lee N. Y. Rapid diagnosis of tuberculosis and multidrug resistance using a MGIT 960 system. Ann Lab Med. 32, 264–269 (2012). - PMC - PubMed
    1. Marais B. J. The global tuberculosis situation and the inexorable rise of drug-resistant disease. Adv Drug Deliv Rev. 12, 2016; doi: 10.1016/j.addr.2016.01.021 (2016). - DOI - PubMed
    1. WHO Global tuberculosis report 2015. WHO/HTM/TB/2015.22. Geneva, Switzerland: WHO. (2015). Available at: http://who.int/tb/publications/global_report/en/ Accessed March 3rd 2015.

Publication types

MeSH terms